antipsychotic

(redirected from first-generation antipsychotic)
Also found in: Thesaurus, Medical, Acronyms.

an·ti·psy·chot·ic

 (ăn′tē-sī-kŏt′ĭk, ăn′tī-)
adj.
Counteracting or diminishing the symptoms of psychotic disorders, such as schizophrenia.
n.
An antipsychotic drug.

antipsychotic

(ˌæntɪsaɪˈkɒtɪk)
adj
(Psychiatry) preventing or treating psychosis
n
(Pharmacology) any antipsychotic drug, such as chlorpromazine: used to treat such conditions as schizophrenia

an•ti•psy•chot•ic

(ˌæn ti saɪˈkɒt ɪk, ˌæn taɪ-)

adj.
1. of or pertaining to any of various drugs used in the treatment of psychosis, esp. schizophrenia, and severe states of mania, depression, or paranoia.
n.
2. Also called neuroleptic. an antipsychotic drug.
[1950–55]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.antipsychotic - tranquilizer used to treat psychotic conditions when a calming effect is desiredantipsychotic - tranquilizer used to treat psychotic conditions when a calming effect is desired
chlorpromazine, Thorazine - a drug (trade name Thorazine) derived from phenothiazine that has antipsychotic effects and is used as a sedative and tranquilizer
clozapine, Clozaril - an antipsychotic drug (trade name Clozaril) used as a sedative and for treatment-resistant schizophrenia; know to have few side effects
diphenylbutyl piperidine - a group of antipsychotic drugs used mainly in the treatment of schizophrenia
fluphenazine - tranquilizer used to treat psychotic disorders
Haldol, haloperidol - tranquilizer (trade name Haldol) used to treat some psychotic disorders and Tourette's syndrome
loxapine, Loxitane - a tranquilizer (trade name Loxitane) used to treat schizophrenia
Moban, molindone - antipsychotic drug (trade name Moban) used in the treatment of schizophrenia
prochlorperazine - antipsychotic and antiemetic drug used to treat schizophrenia and to combat nausea and vomiting
Mellaril, thioridazine - a tranquilizer (trade name Mellaril) used to treat schizophrenia and other psychotic disorders
Navane, thiothixene - a tranquilizer (trade name Navane) used to treat schizophrenia
antianxiety agent, ataractic, ataractic agent, ataractic drug, tranquilizer, tranquilliser, tranquillizer - a drug used to reduce stress or tension without reducing mental clarity
Eskalith, Lithane, lithium carbonate, Lithonate - a white powder (LiCO3) used in manufacturing glass and ceramics and as a drug; the drug (trade names Lithane or Lithonate or Eskalith) is used to treat some forms of depression and manic episodes of manic-depressive disorder
Translations

antipsychotic

adj & n antipsicótico
References in periodicals archive ?
Medications (table 1 (5,8)) are grouped into first-generation antipsychotics (FGAs) and second-generation, or atypical, antipsychotics (SGAs), with the 2 classes being equally effective.
2) The first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) remain the cornerstone of treatment in the acute phase as well as for long-term maintenance therapy.
Reasons for switching from first-generation antipsychotic to second-generation antipsychotic
Approximately 50% percent of patients with schizophrenia report sexual dysfunction during treatment with first-generation antipsychotic medications.
Action on the mesolimbic pathway is thought to be responsible for their effects on schizophrenia symptoms, (2) while action at receptor sites in other dopaminergic pathways leads to common adverse effects, primarily the extrapyramidal symptoms (EPS) associated with first-generation antipsychotics (FGAs).
However, patients on a first-generation antipsychotic agent had a 3.
While both the classification and relative efficacies of the so-called 'typical' first-generation antipsychotic (FGA) agents, such as haloperidol and chlorpromazine, and 'atypical' second-generation antipsychotic (SGA) compounds, such as risperidone and olanzapine, remain controversial, current evidence supports the following:
7%) patients had a trial on a first-generation antipsychotic, and only 10 (14.
The study describes differences in patient characteristics and antipsychotic use patterns between those who received the two first-generation antipsychotic depot formulations and those who received oral formulations.
8) A study by Liao et al (9) investigated the risk of developing type 2 diabetes mellitus, hypertension, and hyperlipidemia in patients with schizophrenia who received treatment with a first-generation antipsychotic (FGA) compared with patients who received a SGA.
A link between schizophrenia and diabetes was postulated in the 1920s, (12) and a temporal association between first-generation antipsychotic drug treatment and hyperglycemia was first reported in the 1950s.